S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0070
-0.0002 (-2.78%)
Sep 2, 2026, 5:29 PM CET
S2Medical AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6 | 9 | 9 | 17 | 22 | 79 | |
Market Cap Growth | -42.17% | 1.91% | -46.36% | -25.20% | -72.04% | -12.55% |
Enterprise Value | 6 | 8 | 7 | 15 | 19 | 74 |
Last Close Price | 0.01 | 0.01 | 0.01 | 0.05 | 0.52 | 4.05 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 1.84 | - | - | - |
PS Ratio | 0.45 | 0.56 | 0.60 | 2.14 | 3.59 | 7.43 |
PB Ratio | 0.63 | 0.92 | 0.47 | 9.97 | 3.13 | 5.38 |
P/TBV Ratio | 0.76 | 1.12 | 0.53 | 1670.08 | 4.30 | 6.40 |
P/FCF Ratio | - | 13.36 | 1.76 | - | - | - |
P/OCF Ratio | - | 13.36 | 1.76 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.41 | 0.48 | 0.51 | 1.95 | 3.04 | 6.99 |
EV/EBITDA Ratio | - | - | 1.36 | - | - | - |
EV/EBIT Ratio | - | - | 1.55 | - | - | - |
EV/FCF Ratio | - | 11.45 | 1.49 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | - | - | - | - | 0.01 |
Net Debt / Equity Ratio | -0.06 | -0.09 | -0.05 | -0.91 | -0.53 | -0.63 |
Net Debt / EBITDA Ratio | 0.41 | 0.45 | -0.18 | 0.11 | 0.14 | 0.50 |
Net Debt / FCF Ratio | 1.27 | -1.34 | -0.20 | 0.09 | 0.13 | 0.47 |
Asset Turnover | 0.66 | 0.76 | 0.63 | 0.33 | 0.22 | 0.30 |
Inventory Turnover | 1.18 | 1.37 | 0.22 | 0.47 | 0.18 | 0.77 |
Quick Ratio | 0.34 | 0.26 | 0.50 | 0.17 | 0.29 | 0.72 |
Current Ratio | 0.59 | 0.56 | 0.87 | 0.44 | 0.66 | 1.08 |
Return on Equity (ROE) | -69.59% | -70.61% | 47.23% | -520.39% | -270.86% | -84.27% |
Return on Assets (ROA) | -5.64% | -7.88% | 12.90% | -40.86% | -62.96% | -34.85% |
Return on Capital Employed (ROCE) | -19.20% | -27.00% | 25.80% | -920.60% | -391.70% | -135.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -158.66% | -111.73% | 54.27% | -137.40% | -133.32% | -25.41% |
FCF Yield | -7.01% | 7.49% | 56.75% | -99.96% | -128.26% | -25.12% |
Buyback Yield / Dilution | - | -53.03% | -360.86% | -411.02% | -60.30% | -26.41% |